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Abstract: The aim of this review was to determine the relationship between dairy product
consumption and arterial stiffness, measured by pulse wave velocity (PWV). We systematically
searched the Medline, Embase and Web of Science databases until 30 January 2019 for cross-sectional
data from studies addressing the association between dairy product consumption and PWV.
This study was registered with PROSPERO (CRD42018110528). Both the inverse-variance fixed
effects method and the DerSimonian and Laird method were used to compute pooled estimates of
effect size (ES) and the respective 95% confidence intervals (CIs). Seven studies were included in
the meta-analysis, with a total of 16,443 patients. Total dairy product (ES = −0.03; 95% CI [−0.04,
−0.01]) and cheese (ES = −0.04; 95% CI [−0.07, −0.01]) consumption were weak, but significantly
associated with lower PWV levels. Conversely, milk intake showed no significant association with
PWV (ES = 0.02; 95% CI [−0.01, 0.05]). Heterogeneity in the ES was not important for the three
groups of dairy products assessed. This systematic review and meta-analysis of seven studies found
no detrimental effects of dairy product consumption on arterial stiffness measured by PWV. Due to
the scarcity of studies, further investigations are warranted to clarify the role of dairy products on
arterial stiffness.
Keywords: arterial stiffness; pulse wave velocity; dairy product; milk; meta-analysis; systematic review
1. Introduction
Cardiovascular disease (CVD) represents the main cause of mortality worldwide [1]. Certain
behaviors, such as an unhealthy diet and physical inactivity, have increased in parallel with the
prevalence of CVD risk factors, including obesity, hypertension and diabetes. Increasingly, evidence
from longitudinal studies consistently supports a negative association between dairy product intake
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and the risk of CVD, which is in accordance with observational studies that report a negative association
between milk intake and obesity [2], diabetes [3] and hypertension [4]. Moreover, a recent meta-analysis
of prospective studies have also shown a null or weak inverse effect of dairy products on CVD [5].
Similarly, recent studies have reported that dairy product intake is associated with other CVD
risk indicators, such as arterial stiffness [6]. A characteristic of the aging process is the stiffening of
large arteries, which may promote the progression of some chronic diseases, particularly hypertension.
Conversely, certain behaviors, such as smoking, a sedentary lifestyle or unhealthy diet, and certain
cardiometabolic diseases, such as obesity and type 2 diabetes mellitus, are consistently correlated with
the progression of arterial stiffness [7–9].
Dairy products include milk, cream, butter, cheese, yogurt, frozen desserts and whey, among
others. They contain several micro- and macronutrients, including saturated fatty acids (SFAs). Indeed,
the SFA content is the main reason why dairy product intake has received an unfavorable reputation in
recent years [10]. The literature examining the relationship between dairy product intake and arterial
stiffness is scarce and findings are inconsistent, although recent results from the Prospective Urban
Rural Epidemiology (PURE) multinational cohort study suggest that dairy consumption might be
associated with a lower risk of mortality and major cardiovascular disease events [11]. Moreover,
recent meta-synthesis studies have addressed the relationship between milk and dairy consumption
and CVD [12], diabetes [13] and all-cause mortality [14].
Increased aortic pulse wave velocity (PWV), the most valid and reliable measure of arterial
stiffness, has been associated with a higher risk of cardiovascular events and all-cause mortality.
A systematic review and meta-analysis [6] reported that the prediction ability of arterial stiffness
is higher in subjects at increased risk of cardiovascular disease, estimating a 14% increase in total
cardiovascular risk with every 1 m/s increase in PWV. Among the indexes proposed to estimate PWV,
carotid-femoral pulse wave velocity (cfPWV) is accepted as the gold standard noninvasive method [15].
This systematic review and meta-analysis aimed to synthesize the evidence of the relationship
between the consumption of dairy products and arterial stiffness (measured by PWV).
2. Materials and Methods
This systematic review and meta-analysis is reported according to the Preferred Reporting Items
for Systematic Reviews and Meta-analyses (PRISMA) guidelines [16] (Figure 1), and follows the
recommendations of the Cochrane Collaboration Handbook [17]. The study was also registered through the
International Prospective Register of Systematic Reviews (registration number: CRD42018110528).
2.1. Data Sources and Searches
We systematically searched MEDLINE (via PubMed), EMBASE and Web of Science databases
from their inception until 30 January 2019. The search strategy included, combined with Boolean
operators, the following terms: milk, dairy, dairy product, dairy product consumption, dairy product
intake, dairy intake, pulse wave velocity, arterial stiffness, PWV, arterial aging, aortic stiffness (Table 1).
The literature search was complemented by reviewing the reference lists of articles considered eligible
for the systematic review. Authors were contacted to obtain missing information when necessary.
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Table 1. Search strategy for Medline.
Dairy Related Terms Arterial Stiffness Related Terms
“milk”
OR
“dairy”
OR
“dairy product”
OR
“dairy product consumption”
OR
“dairy product intake”
“dairy intake”
AND
“pulse wave velocity”
OR
“arterial stiffness”
OR
“PWV”
R
“arterial aging”
OR
“aortic stiffness”
2.2. Study Selection
The criteria for including studies were as follows: (i) individuals from population-based samples;
(ii) study design including cross-sectional studies or baseline measurements of cohort studies and
RCTs; (iii) exposure to dairy products consumption, milk, cheese, yogurt, butter or other type of dairy
product; and (iv) arterial stiffness as the outcome, measured using PWV. Th crit ria for excluding
st i s were as follows: (i) reports not written in English or Spanish; and (ii) non-eligi le publication
t s, such as review articles, editori ls, comments, guidelines or case-reports.
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The literature search was independently conducted by two reviewers (AD-F and IC-R),
and disagreements were resolved by consensus or by consultation with a third researcher (CA-B).
2.3. Data Extraction and Quality Assessment
The following data were extracted from the original reports: (1) first author and year of publication;
(2) country where data for the study were collected; (3) sample characteristics (type of design, sample
size, average age and distribution, average systolic blood pressure (SBP), average diastolic blood
pressure (DBP) and average body mass index (BMI)); (4) type of record and quantity of dairy products
consumed; and (5) PWV mean value, measurement site and device used.
The Quality Assessment Tool for Observational Cohort and Cross-sectional Studies published
by the National Heart, Lung and Blood Institute was used to evaluate the risk of bias of cohort and
cross-sectional studies [18]. The methodological criteria included: research question, population
definition, participation rate, recruitment, sample size, analysis, timeframe, exposure levels, measures
and assessment, outcome measures and blinding, loss to follow-up, and confounding variables.
Each study was rated as either good (i.e., most criteria met with a low risk of bias), fair (i.e., some
criteria met with a moderate risk of bias), or poor (i.e., few criteria met and with a high risk of bias).
Rating of studies was independently performed by two reviewers (AD-F and IC-R), and inconsistencies
were resolved by consensus or by consulting a third researcher (CA-B).
2.4. Statistical Analysis
Both the inverse-variance fixed effects method [19] and the DerSimonian and Laird method were
used to compute pooled estimates of effect size (ES) and the respective 95% confidence intervals
(CI). When studies presented this association by regression models or mean value trends by group,
the ES [20] was calculated. Values of ES of around 0.2 were considered a weak effect, values
around 0.5 indicated a moderate effect, values around 0.8 represented a strong effect, and values
larger than 1.0 were considered a very strong effect. Considering the differing composition of
dairy products, the meta-analysis considered the type of dairy products, the pooled estimates by
the type of dairy products were calculated only when there was three or more studies (total, milk and
cheese); thus, other type of dairy products, such as cream, butter, yogurt, frozen desserts or whey
were not individually analyzed. The heterogeneity of results across studies was assessed using the
I2 statistic. I2 values were considered as: 0–40%, might not be important; 30–60%, may represent
moderate heterogeneity; 50–90%, substantial heterogeneity; or 75–100%, considerable heterogeneity.
The corresponding p-values were also taken into account [17].
Sensitivity analyses (systematic re-analysis while removing studies one at a time) were conducted
to assess the robustness of the summary estimates and to provide insight as to whether any particular
study accounted for a large proportion of heterogeneity amongst the pooled ES.
Random-effects meta-regression analyses were performed to determine whether age, BMI, SBP,
DBP or pulse pressure (PP) were significant moderators for the relationship between dairy products
and PWV.
Publication bias was assessed by the Harbord modified test [21], and was considered statistically
significant at a p-value of <0.10. Statistical analyses were performed using Stata/SE software version 14
(College Station, TX, USA).
3. Results
3.1. Systematic Review
The PRISMA flow diagram is presented in Figure 1. From the 208 full-text articles identified,
only seven studies met the inclusion criteria and were included in the systematic review. These studies
were published between 2012 and 2018, included sample sizes ranging from 22 to 12,892 participants,
and data was collected from samples from Europe, North and South America and Oceania. A total
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of 16,427 patients met the inclusion criteria and were included in the analysis. Six studies included
an adult population (mean age ranged from 26.3 ± 4.2 to 63.8 ± 12.4 years) [22–27], and one study
included children and adolescent patients (13.2 ± 0.7 years) [28]. All studies determined arterial
stiffness through the carotid-femoral PWV, with six studies using the SphygmoCor system (AtCor
Medical Pty Ltd., West Ryde, Australia) while the other one used the Complior automatic device
(Artech Medical, France) [24]. Dairy product consumption was estimated with different questionnaires
that recorded the frequency and type of dairy product consumed (Table 2).
Of the studies reviewed, five focused on overweight participants [23–25,27,28] while the remaining
two studies included obese samples [22,26]. Furthermore, five studies focused on subjects with elevated
blood pressure (BP), one study focused on subjects with normal BP, and the other study focused on
subjects with stage 1 hypertension [25] (Table 2).
Six studies analyzed the consumption of total dairy products [22–27] and one only included
milk intake [28]. Milk and cheese could be analyzed separately since four [24–26,28] and three
studies [24–26], respectively, included the information. Butter and yogurt could not be analyzed due to
the lack of results in the studies (only one study included butter [24] and two included yogurt [24,26]).
Four studies showed negative associations between total dairy products and PWV [22–24,26]
while two found a positive association [25,27]. Regarding milk intake, two studies found a negative
association with PWV [26,28] and the other two describe a positive association [24,25]. Finally, cheese
consumption was negatively associated with PWV in all included studies [24–26]. It is remarkable that
all associations between total dairy products, milk and cheese with PWV were discrete.
Each study used a different questionnaire to assess participant’s dietary records. Among their
similarities, three of them presented their results across categories of frequency of consumption of dairy
products [23–25]. Two studies collected the data through electronic versions of the questionnaires [22,26],
three collected the data at the moment of the interview [24,25,27], one required participants to fulfil
a booklet every day for four days [28] and other was completed within 2 weeks of the laboratory visit by
the participants [23].
Age was included as a covariate in all studies, and most of them also included as covariates
anthropometric (BMI or waist circumference) [22–24,26,28], biochemical (high-density lipoprotein
(HDL) and/or low-density lipoprotein (LDL) cholesterol, triglycerides (TG)) [23,24,27,28], the use of
antihypertensive medication [23–27] and some blood pressure-related variables such as mean arterial
pressure (MAP) or SBP (Table 2).
Nutrients 2019, 11, 741 6 of 14
Table 2. Characteristics of the studies included.
Study Country/Typeof Design
n/Mean Age
(Years)
Mean BMI
(kg/m2)
Mean SBP/DBP
(mmHg)
Mean PWV
(m/sec) Dietary Record
Type of Dairy
Product
Mean Dairy
Products
Consumption
Main Results Covariables
Arnberg K et al,
2012 [28]
Denmark/
Cross-sectional 193/13.2 ± 0.7 25.2 ± 2.3 111 ± 7/65.3 ± 6.3 4.81 ± 0.71
Precoded food
record of 4 days [29] Milk 224 g/d
Negative association
between milk intake
and PWV.
Age, gender, MAP, Tanner
stage, heart rate, HOMA,
serum TG, serum HDL
cholesterol and BMI.
Campbell M et
al, 2018 [22]
USA/
Cross-sectional 22/26.3 ± 4.2 33.2 ± 3.5 124.3 ± 8.5/79.5 ± 7.6 6.34 ± 0.88
DHQ-II of one
month [30] Dairy products 194.25 g/d
Negative correlation
between dairy products
and PWV.
Age, BMI, MAP, SBP, PP and
waist circumference.
Crichton G et al,
2012 [23]
USA/
Cross-sectional 587/63.8±12.4 29.5 ± 6.4 128.9 ± 19.6/77 ± 9.3 10.25 ± 2.8
Nutrition and
Health
questionnaire [31]
Milk and dairy
product NA
According to categories
of dairy products
frequency consumption,
higher intake of dairy
food was related with
lower PWV, PP, and
SBP values.
Age, education, sex, race,
weight, heart rate,
antihypertensive drug
treatment, MAP, waist
circumference, total cholesterol,
HDL and LDL cholesterol,
Center for Epidemiologic
Studies Depression Scale raw
score + grains per day,
vegetables per day, sweets per
day, protein per day, and total
food servings per day.
Gomes Ribeiro
A et al, 2018 [24]
Brazil/
Cross-sectional 12892/51.6±8.9 26.8 ± 4.6
121.1 ± 17.1/
76.3 ± 10.7 9.31 ± 1.81
Semi-quantitative
FFQ [32]
Milk, cheese,
yogurt, butter 316.60 g/d
Inverse association
between the intake of
dairy products with
SBP, PP and PWV.
Higher frequency of
dairy product
consumption was
significantly associated
with lower PWV values.
Age, sex, race, income, weight,
height, waist circumference,
smoking status, alcohol intake,
physical activity, fasting
glucose, total cholesterol, MAP,
antidiabetic drugs (yes/no),
lipid-lowering drugs (yes/no),
antihypertensive drugs
(yes/no), calorie intake and
non-dairy food groups.
Livingstone K et
al, 2013 [25]
UK/Longitudinal
and
cross-sectional
2373/56.9 ± 4.5 26.4 ± 3.5 144.3 ± 18.5/84.9 ±10.1 11.47 ± 2.67 FFQ [33]
Milk, cheese,
butter and
cream
346 g/d
Higher intake of dairy
products significantly
decreased PP and SBP
values, but there were
not differences in PWV
results across quartiles
of dairy product
consumption.
Age, alcohol consumption,
smoking habits, social class,
physical activity, total energy
intake, and fat intake, heart
rate, MAP, and drug use.
Petersen K et al,
2015 [26]
Australia/
Cross-sectional 95/58.0±12.0 34.0 ± 6.9 129 ± 14/73 ± 10 9.6 ± 1.8
DQES v2 FFQ of 3
days [34]
Milk, yogurt
and cheese 387 g/d
Significant inverse
association between
total dairy intake and
yogurt with PWV.
Age, central MAP, BMI, heart
rate and antihypertensive
medication prescription.
Recio-Rodriguez
JI et al 2014 [27]
Spain/
Cross-sectional 265/55.9±12.2 27.3 ± 4.3
122.3 ± 17.9/77.6 ±
10.8 7.60 ± 2.00
Semi-quantitative
137-item FFQ [35]
High-fat dairy
and low-fat
dairy
133.1 g/d
Low-fat dairy products
consumption was
associated with lower
PWV values, but
whole-fat products
increased PWV values.
Age, sex, BMI, smoking, SBP,
total cholesterol, energy intake
and the presence of diabetes,
antihypertensive, antidiabetic
and lipid-lowering drugs.
BMI: Body mass Index; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; PWV: Pulse Wave Velocity; m/sec: meters/second; FFQ: Food-frequency questionnaire.
NA: Not available.
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3.2. Risk of Bias
According to the Quality Assessment Tool for Observational Cohort and Cross-sectional Studies,
all studies included in the meta-analysis were considered as having a low risk of bias (Table 3).
Table 3. Quality assessment tool for observational cohort and cross-sectional studies.
A
rnberg
K
etal,2012
C
am
pbellM
etal,2018
C
richton
G
etal,2012
G
om
es
R
ibeiro
A
etal,2018
Livingstone
K
etal,2013
Petersen
K
etal,2015
R
ecio-R
odriguez
JI
etal,2014
1. Was the research question or objective in this paper
clearly stated?
Yes Yes Yes Yes Yes Yes Yes
2. Was the study population clearly specified
and defined?
Yes Yes Yes Yes Yes Yes Yes
3. Was the participation rate of eligible persons at
least 50%?
Yes NA Yes Yes Yes Yes NA
4. Were all the subjects selected or recruited from the same
or similar populations (including the same time period)?
Were inclusion and exclusion criteria for being in the study
prespecified and applied uniformly to all participants?
Yes Yes Yes Yes Yes Yes Yes
5. Was a sample size justification, power description,
or variance and effect estimates provided?
No No No Yes No No Yes
6. For the analyses in this paper, were the exposure(s) of
interest measured prior to the outcome(s)
being measured?
No No No No No No No
7. Was the timeframe sufficient so that one could
reasonably expect to see an association between exposure
and outcome if it existed?
No No No No No No No
8. For exposures that can vary in amount or level, did the
study examine different levels of the exposure as related
to the outcome (e.g., categories of exposure, or exposure
measured as continuous variable)?
No No Yes Yes Yes No No
9. Were the exposure measures (independent variables)
clearly defined, valid, reliable, and implemented
consistently across all study participants?
Yes Yes Yes Yes Yes Yes Yes
10. Was the exposure(s) assessed more than once
over time?
NA NA NA NA NA NA NA
11. Were the outcome measures (dependent variables)
clearly defined, valid, reliable, and implemented
consistently across all study participants?
Yes Yes Yes Yes Yes Yes Yes
12. Were the outcome assessors blinded to the exposure
status of participants?
Yes Yes Yes Yes Yes Yes Yes
13. Was loss to follow-up after baseline 20% or less? NA NA NA NA NA NA NA
14. Were key potential confounding variables measured
and adjusted statistically for their impact on the
relationship between exposure(s) and outcome(s)?
Yes Yes Yes Yes Yes Yes Yes
NA: Not applicable.
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3.3. Meta-Analysis
Figure 2 presents the ES for each of the dairy products consumed and the PWV. Total dairy
products (ES = −0.03; 95% CI [−0.04, −0.01]) and cheese (ES = −0.04; 95% CI [−0.07, −0.01])
consumption were weak but significantly associated with lower PWV levels. Conversely, milk
consumption showed no significant association with PWV (ES = 0.02; 95% CI [−0.01, 0.05]).
Heterogeneity in the ES was not important for the three groups of dairy products: total dairy products
(I2 = 0.0%; p = 0.839), milk (I2 = 0.0%; p = 0.930), and cheese (I2 = 4.2%; p = 0.352).
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3.4. Sensitivity Analysis
When the impact of individual studies was examined by removing studies from the analysis one
at a time, we observed that the pooled ES estimate was modified for total dairy products (ES = −0.01,
95% CI [−0.08, 0.05]) and cheese (ES = −0.02, 95% CI [−0.10, 0.06]) consumption only after removing
data from the study by Gomes-Ribeiro et al. (Table 4).
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Table 4. Sensitivity analysis by removing one by one the included studies.
References ES (95% CI) I2 p
TOTAL DAIRY PRODUCTS
Campbell M et al, 2018 [22] −0.03 (−0.04, −0.01) 0.0 0.725
Crichton G et al, 2012 [23] −0.03 (−0.04, −0.01) 0.0 0.888
Gomes Ribeiro A et al, 2018 [24] −0.01 (−0.08, 0.05) 0.0 0.785
Livingstone K et al, 2013 [25] −0.03 (−0.05, −0.02) 0.0 0.889
Petersen K et al, 2015 [26] −0.03 (−0.04, −0.01) 0.0 0.722
Recio-Rodríguez JI et al, 2014 [27] −0.03 (−0.04, −0.01) 0.0 0.759
MILK
Arnberg K et al, 2012 [28] 0.02 (−0.01, 0.05) 0.0 0.954
Gomes Ribeiro A et al, 2018 [24] 0.00 (−0.07, 0.08) 0.0 0.866
Livingstone K et al, 2013 [25] 0.02 (−0.01, 0.05) 0.0 0.815
Petersen K et al, 2015 [26] 0.02 (−0.01, 0.05) 0.0 0.815
CHEESE
Gomes Ribeiro A et al, 2018 [24] −0.08 (−0.31, 0.15) 47.5 0.168
Livingstone K et al, 2013 [25] −0.04 (−0.07, −0.01) 36.0 0.211
Petersen K et al, 2015 [26] −0.04 (−0.06, −0.01) 0.0 0.815
3.5. Meta-Regression
Due to the limited number of studies, random-effects meta-regression models were conducted
only for total dairy product consumption. These analyses indicated that age (p = 0.983), BMI (p = 0.518),
SBP (p = 0.461), DBP (p = 0.395) and PP (p = 0.512) were not related to the pooled ES estimates (Table 5).
Table 5. Meta-regressions of the PWV and total dairy products consumption by age, body mass
index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP) and pulse pressure (PP) of
included studies.
Covariates ß (95% CI) p
Age (years) −0.00 (−0.01, 0.01) 0.983
BMI (kg/m2) −0.01 (−0.07, 0.04) 0.518
SBP (mmHg) 0.00 (−0.00, 0.01) 0.461
DBP (mmHg) 0.00 (−0.01, 0.02) 0.395
PP (mmHg) 0.00 (−0.01, 0.01) 0.512
SBP: Systolic blood pressure; DBP: Diastolic blood pressure; PP: Pulse pressure.
3.6. Publication Bias
The Harbord modified test for publication bias was performed only for total dairy products and
showed no evidence of publication bias (p = 0.877) (Figure 3).
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4. Discussion
This systematic review and meta-analysis synthetized the current available evidence regarding
the association between dairy product consumption and PWV. We found a significant association of
total dairy and cheese consumption with slightly lower PWV levels. However, no association between
milk consumption and PWV was observed.
In our analysis, we found an overall statistically significant association between total dairy
product intake and lower PWV, although the effect estimates were small. This association was mainly
driven by the study by Gomez-Ribeiro et al. However, it is worth noting that, of the six studies
analyzed in the category of total dairy products, only three separately analyzed the consumption of
whole-fat and low-fat dairy [24,26,27]. While two studies did not find an association between PWV
and whole-fat dairy, Recio-Rodriguez found opposite associations based on the fat content. Specifically,
for every 100 g/day increase in low-fat dairy intake there was a decrease in PWV of 0.10 m/s (p = 0.011),
while the same amount of high-fat dairy resulted in a similar increase in PWV (0.109 m/s; p = 0.038).
In another cross-sectional study, Crichton et al. found that dairy product intake (80.4% of which
was reduced-fat milk) was inversely associated with PWV. Low-fat dairy, but not whole-fat dairy,
was associated with lower PWV in the ELSA-Brazil study [24]. Due to the cross-sectional nature of the
previous results [27], these findings should be interpreted with caution. Moreover, given that data from
another meta-analysis supports a negative association between total dairy product intake and CVD
risk [12], together with the null association of whole-fat dairy intake reported in some studies [24,26],
we suggest that conclusions for whole-fat dairy products cannot be made until we have results from
well-designed follow-up or experimental studies, in accordance with all authors of the studies included
in the systematic review which stated that more prospective, randomized, population-based studies
are needed to reinforce their results.
Blood pressure is one of the major determinants of arterial stiffness [36]. The various components
of dairy products may explain the health benefits found in different studies. For example, the bioactive
peptides present in dairy products may inhibit the angiotensin-I-converting enzyme, which is involved
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in the regulation of blood pressure [37,38]. Similarly, milk-derived bioactive peptides produced by
the proteolysis of casein and whey have been suggested to play a role in atherosclerosis. Consistent
with these biochemical mechanisms, in the prospective cohort from the Caerphilly Prospective Study,
those with the highest milk intake showed a lower SBP when compared with those who did not
consume milk, and milk and dairy product intake was not associated with arterial stiffening. Indeed,
only butter intake was positively associated with blood pressure and arterial stiffness indicators in that
study [25]. The authors highlighted that they only included whole-fat milk in their analysis. We did
not include butter in this meta-analysis because from the seven studies included in this meta-analysis,
only the cross-sectional ELSA-Brasil study included butter separately in their analyses [24], reporting
a significant negative association between butter intake and carotid-femoral PWV, but no association
with SBP and PP. Our pooled estimates did not show a significant association between milk intake
and arterial stiffening; however, due to the scarcity of studies, these estimates should be interpreted
with caution.
With regard to cheese consumption, three studies included in this meta-analysis showed
an overall significant association between cheese consumption and a lower PWV, although this
finding was mostly driven by the results from the study by Gomes-Ribeiro et al. In their cross-sectional
study, the authors reported that cheese (one serving per day) was inversely associated with PVW
(cfPWV = −0.02 m/s [−0.04, −0.01]). As our results were strongly influenced by this study, we suggest
that more research should address this issue. Similarly, the results of research analyzing the
effect of dietary and nutrient interventions on the treatment of arterial stiffness, although limited,
supports that Lactobacillus helveticus-fermented milk products and products containing tripeptides [39]
improve arterial stiffness (Cohen’s d = 0.15–0.33) in hypertensive patients [40]. In the case of cheese
consumption, because this dairy product contains a high amount of salt, further research is needed
to investigate whether the specific type of cheese is relevant. Finally, yogurt was not evaluated in
this meta-analysis because our search retrieved only two studies that specifically assessed its effect
on arterial stiffness [24,26], although the ES estimates for these studies indicated a lower inverse
association between yogurt consumption and PWV (−0.04 [−0.07, −0.01]). Thus, these results are
inconclusive. Likewise, the evidence for a hypotensive effect of yogurt is controversial, as although
some studies suggest a hypotensive effect [41,42], a previous meta-analysis reported moderate- to
high-quality evidence that the consumption of high-fat dairy, cheese, yogurt and fermented dairy
products are not associated with the risk of hypertension [42].
Limitations
Some limitations in this systematic review and meta-analysis should be acknowledged:
(1) the limited number of studies did not allow us to specifically analyze the association of each type
of dairy product; (2) we could not evaluate changes or the effect of interventions on the relationship
between milk intake and arterial stiffness due to the cross-sectional nature of the included studies;
(3) the study conducted by Gomes-Ribeiro and colleagues had a markedly greater sample size when
compared to the other studies, although sensitivity analyses did not show a change in the results
after removing this study; (4) different validated food frequency questionnaires were used across
studies, therefore, the data for dairy product consumption were not similar across studies which
might affect the reliability of our results; and (5) although the Cochrane Handbook recommends that
a meta-regression analyses only be conducted when there are 10 or more studies in the meta-analysis,
we performed this statistical test for total dairy product consumption in order to obtain a picture of
the impact of certain risk factors of disputed influence on PWV, such as age or blood pressure, on our
estimates. Thus, the findings of these analyses should be interpreted with caution.
5. Conclusions
Overall, we found no detrimental effect of dairy product consumption on arterial stiffness,
as measured by PWV. An inverse association with PWV was found for total dairy and cheese
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consumption. However, our results should be interpreted with caution because most of the evidence
comes from cross-sectional studies (seven studies). Well-designed, randomized controlled trials and
follow-up studies are warranted to clarify the role of dairy products on arterial stiffness.
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